Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
The scholar is funded by an endowment established by world-renowned ophthalmologist and Dartmouth alumnus Francis A. L’Esperance, Jr., MD, (MED’54), which supports research in ophthalmology and diseases of the eye.
More than $12 million over five years has been awarded for research collaboration to more precisely determine lung cancer risk and improve screening.
A team of Dartmouth researchers has found that mothers who have developed antibodies against the herpes simplex virus (HSV-1) can pass these antibodies to the nervous systems of their infants, protecting them from acquiring the virus.
Physician and scientist Steven D. Leach, MD, has been selected as the new Director of the Norris Cotton Cancer Center. The appointment was announced today by Dr. Duane Compton, dean of the Geisel School of Medicine at Dartmouth, and Dr. James N. Weinstein, CEO and President of Dartmouth-Hitchcock.
William Wickner, MD, a professor of biochemistry and cell biology, recently received the William C. Rose Award from the American Society for Biochemistry and Molecular Biology.
Alyssa Flores (’19) has been awarded a prestigious Howard Hughes Medical Institute Medical Research Fellowship and will receive support for one year of mentored and in-depth training in biomedical research.
Dartmouth medical alumnus Russell Andrews (MED ’78)—a neurosurgeon in California—has been part of a collaboration between NASA and the Mayo Clinic to develop a new wireless nanoelectrode that could help people with Parkinson’s disease.
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
This page may link to PDF files. Use this link to download Adobe Reader if needed.